Clinical Trials Directory

Trials / Completed

CompletedNCT06062186

Acute Effects of Naturally Occurring Tea and Coffee-based Ingredients on Cognitive Performance

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
The Center for Applied Health Sciences, LLC · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

This study is a double-blind, randomized, three-arm, single-dose, placebo-controlled crossover trial of forty (40) apparently healthy male and female participants. The objective of this study is to assess the effects of AmaTea Max Organic Guayusa Extract and Lion's Mane on cognitive responses including mental clarity, mood, focus, concentration, productivity, anxiety/stress, happiness, and accuracy.

Detailed description

This study is a double-blind, randomized, three-arm, single-dose, placebo-controlled crossover trial of forty (40) apparently healthy male and female participants. The objective of this study is to assess the effects of AmaTea Max Organic Guayusa Extract and Lion's Mane on cognitive responses including mental clarity, mood, focus, concentration, productivity, anxiety/stress, happiness, and accuracy. Since these dietary supplements are on the market for consumer use, it is important to investigate and confirm their potential benefits, comparisons, and safety through further research. Subjects will attend 4 study visits. During Visit 1, subjects will be screened for participation (i.e., medical history, routine blood work, background baseline diet). During Visits 2, 3 and 4, at 3 time points (pre-ingestion, 60 and 120 minutes post ingestion), participants will complete subjective baseline testing including questionnaires that assess mental clarity, mood, focus, concentration, productivity, anxiety/stress, and the Happiness Scale in addition to completing a series of objective neuropsychological tests (e.g., Go/no-go test, N-back test, Serial Sevens test) to assess cognitive performance. Safety will be monitored via vital signs (heart rate, blood pressure) and adverse events (AE) throughout study.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPlacebo650 mg of placebo, given as two capsules containing maltodextrin
DIETARY_SUPPLEMENTAmaTea Guayusa Extract650 mg of AmaTea Guayusa Extract, given as two capsules
DIETARY_SUPPLEMENTLion's Mane1000 mg of Lion's Mane, given as two capsules

Timeline

Start date
2023-04-05
Primary completion
2023-08-28
Completion
2023-09-15
First posted
2023-10-02
Last updated
2023-10-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06062186. Inclusion in this directory is not an endorsement.